MENU
+Compare
SPRO
Stock ticker: NASDAQ
AS OF
Apr 3, 03:17 PM (EDT)
Price
$0.63
Change
-$0.08 (-11.27%)
Capitalization
39.47M

SPRO Spero Therapeutics Forecast, Technical & Fundamental Analysis

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more

SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SPRO with price predictions
Apr 02, 2025

SPRO's Stochastic Oscillator stays in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SPRO advanced for three days, in of 208 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SPRO moved out of overbought territory on March 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SPRO as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SPRO turned negative on April 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

SPRO moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPRO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SPRO broke above its upper Bollinger Band on March 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SPRO entered a downward trend on March 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.856) is normal, around the industry mean (13.260). P/E Ratio (10.751) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1.393) is also within normal values, averaging (252.036).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SPRO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SPRO is expected to report earnings to fall 30.26% to -26 cents per share on May 09

Spero Therapeutics SPRO Stock Earnings Reports
Q1'25
Est.
$-0.26
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.18
Q2'24
Beat
by $0.05
Q1'24
Missed
by $0.12
The last earnings report on March 27 showed earnings per share of -37 cents, missing the estimate of -36 cents. With 216.49K shares outstanding, the current market capitalization sits at 39.47M.
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CADE30.460.05
+0.16%
Cadence Bank
HBCP45.09-0.13
-0.29%
Home Bancorp
JRSH3.38-0.02
-0.59%
Jerash Holdings (US)
WELL153.08-1.07
-0.69%
Welltower
SA11.23-0.22
-1.92%
Seabridge Gold

SPRO and Stocks

Correlation & Price change

A.I.dvisor tells us that SPRO and BCAB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPRO and BCAB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
+1.73%
BCAB - SPRO
31%
Poorly correlated
-3.88%
GNPX - SPRO
29%
Poorly correlated
+28.21%
IMUX - SPRO
29%
Poorly correlated
+4.23%
RAPT - SPRO
28%
Poorly correlated
-0.85%
VCYT - SPRO
28%
Poorly correlated
+1.93%
More